Medicinal – Page 103

The endophytic fungus Cosmosporella sp. VM-42 from Vinca minor is a source of bioactive compounds with potent activity against drug-resistant bacteria

mycolabadmin

Scientists discovered a fungus living inside a medicinal plant called Vinca minor that produces compounds capable of killing drug-resistant bacteria like MRSA. They isolated the main active compound, nectriapyrone, and found it effectively stops the growth of these dangerous bacteria in laboratory tests. The fungus appears to be a promising source of new antibacterial drugs that could help combat the growing problem of antibiotic-resistant infections.

Data analysis of patients with positive mould or dimorphic fungal cultures from sterile sites

mycolabadmin

This study examined 48 patients with serious mould and fungal infections at a South African hospital between 2014-2017. Most infections occurred in people with weak immune systems, especially those with HIV. The most common fungal type was Aspergillus. Even with appropriate antifungal medicines, one-quarter of patients died, highlighting how serious these infections can be.

The 2024 International Society for Human and Animal Mycology (ISHAM)-ABPA working group guidelines: Transforming diagnosis and management of ABPA

mycolabadmin

ABPA is a serious lung disease that develops when the body overreacts to a common fungus called Aspergillus. New international guidelines help doctors better diagnose and treat this condition, which affects many people with asthma and cystic fibrosis. The guidelines make diagnosis easier by using simpler tests and lowering the thresholds for detecting the disease, and they provide clear treatment plans depending on how severe each patient’s disease is. These updated standards are especially important in countries like India where ABPA is very common.

Calcineurin-mediated regulation of growth-associated protein 43 is essential for neurite and synapse formation and protects against α-synuclein-induced degeneration

mycolabadmin

Researchers discovered that a specific protein called GAP-43 plays a crucial role in protecting brain cells from damage caused by α-synuclein, a protein involved in Parkinson’s Disease. When GAP-43 is modified through a process called phosphorylation at certain sites, it promotes the growth of neurites (neural connections) and formation of healthy synapses. The drug FK506, already approved by the FDA, appears to work by controlling this phosphorylation process, offering potential therapeutic benefits for Parkinson’s patients.

Invasive fungal otitis media with peripheral facial paralysis

mycolabadmin

This case describes a rare fungal ear infection caused by Aspergillus fumigatus that spread to the mastoid bone and caused facial nerve paralysis. The patient had ear drainage and hearing loss for 4 years before diagnosis. Treatment required two surgical procedures to remove infected tissue combined with 6 months of antifungal medication, eventually resulting in healing and recovery of facial nerve function.

Mushroom and cereal β-D-glucan solid state NMR and FTIR datasets

mycolabadmin

This research provides a large database of spectroscopic measurements from β-D-glucans extracted from various mushrooms and cereal grains. The data includes detailed chemical fingerprints obtained through two analytical techniques (NMR and infrared spectroscopy) that can help researchers understand the structure and properties of these beneficial compounds. The dataset is freely available for other scientists to analyze and use for developing new methods or understanding how different mushroom and cereal sources vary in their chemical composition.

Safety and efficacy of the swift microwave device in patients with mild-to-moderate onychomycosis: Protocol of an open-label, randomized, dose-finding pilot study

mycolabadmin

This study evaluates a new microwave device (Swift System) as a potential treatment for fungal nail infections (onychomycosis). The device uses microwave energy to heat and eliminate fungal infections directly at the nail site, avoiding the side effects of oral medications. Researchers tested three different treatment schedules in 39 patients over 12 months to find the most effective dosing approach.

Prevalence and antifungal susceptibility profiles of Candida isolates among patients with candiduria: a multiplex PCR assay

mycolabadmin

Researchers studied fungal infections in urine samples from hospitalized patients and found that while the common yeast Candida albicans was most prevalent, other Candida species were increasingly resistant to antifungal medications. Using advanced genetic testing methods, they identified seven different Candida species and tested their resistance to three common antifungal drugs. The findings highlight the growing problem of drug-resistant fungal infections and the need for better diagnostic tools to identify which species is causing infection so appropriate treatment can be selected.

Morpho-phylogenetic evidence reveals novel hyphomycetous fungi on medicinal plants in Southwestern China

mycolabadmin

Researchers discovered 12 new types of fungi living on medicinal plants in Southwest China. These fungi were identified by examining their physical characteristics under a microscope and analyzing their genetic sequences. This discovery helps scientists better understand what kinds of fungi exist on healing plants and may help improve the quality control of traditional Chinese herbal medicines.

Aspergillus terreus IFM 65899-THP-1 cells interaction triggers production of the natural product butyrolactone Ia, an immune suppressive compound

mycolabadmin

Scientists discovered that when a dangerous fungus called Aspergillus terreus is grown together with immune cells, it produces a special compound called butyrolactone Ia that helps it hide from the body’s defense system. This compound works by reducing inflammatory signals that immune cells use to fight the fungus. The research shows that direct contact between the fungus and immune cells is needed to trigger this protective compound production, suggesting the fungus responds directly to the threat of immune attack.

Research Topic: Medicinal